Area of research
Infectious Diseases · Molecular Biology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, vaccines and immunoinformatics approaches, and Immunotherapy and Immune Responses.
Coevolutionary constraints of Zika virus nonstructural protein 5 replication and interferon antagonism activities
Evolution of STAT2 resistance to flavivirus NS5 occurred multiple times despite genetic constraints
SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins
Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans
Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens
Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans
Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population
Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses